Explore more publications!
My Africa News Online
Got News to Share?

My Africa News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 4, 2026

AGES 2026 Delivers Definitive Roadmap to Turn Africa’s Climate Ambition into Bankable, Scalable Reality
Mar. 4, 2026

AGES 2026 Delivers Definitive Roadmap to Turn Africa’s Climate Ambition into Bankable, Scalable Reality

Indeterminate EIN Presswire
MOTA 2026 mettra en lumière l'avenir minier de l'Afrique à Paris — 7-8 juillet 2026
Mar. 4, 2026

MOTA 2026 mettra en lumière l'avenir minier de l'Afrique à Paris — 7-8 juillet 2026

Indeterminate EIN Presswire
AACUC Inducts Five Leaders into 2026 African American Credit Union Hall of Fame
Mar. 4, 2026

AACUC Inducts Five Leaders into 2026 African American Credit Union Hall of Fame

Indeterminate EIN Presswire
Cytespace Africa Laboratories Expands to Drive Cost-Efficient Clinical Trials Across Sub-Saharan Africa
Mar. 4, 2026

Cytespace Africa Laboratories Expands to Drive Cost-Efficient Clinical Trials Across Sub-Saharan Africa

Indeterminate EIN Presswire
Squaretalk Partners with CCSA to Strengthen CX and Outsourcing Capabilities Across Africa
Mar. 4, 2026

Squaretalk Partners with CCSA to Strengthen CX and Outsourcing Capabilities Across Africa

Indeterminate EIN Presswire
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar. 4, 2026

SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar. 4, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
Mar. 4, 2026

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Indeterminate GlobeNewswire
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Mar. 4, 2026

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar. 4, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Spinnaker Support and ARC launch new Third-Party Software Support business in South Africa
Mar. 4, 2026

Spinnaker Support and ARC launch new Third-Party Software Support business in South Africa

Indeterminate EIN Presswire
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review
Mar. 4, 2026

Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review

Indeterminate GlobeNewswire
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Mar. 4, 2026

AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million

Indeterminate GlobeNewswire
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
Mar. 4, 2026

Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar. 4, 2026

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Ardelyx to Participate in Upcoming Investor Conferences
Mar. 4, 2026

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
Mar. 4, 2026

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Indeterminate GlobeNewswire
MEXC Partners with Ondo Finance to Launch Tokenized US Equities in Defense and Energy Sectors
Mar. 4, 2026

MEXC Partners with Ondo Finance to Launch Tokenized US Equities in Defense and Energy Sectors

Indeterminate GlobeNewswire
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
Mar. 4, 2026

BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

Indeterminate GlobeNewswire
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
Mar. 4, 2026

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions